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Vol. 38, pp. 119-127, 1981

Chemical Suppression of Steroidogenesis
by Howard D. Colby*
A large number of chemicals are known to interfere with steroidogenesis in the adrenal
cortex and other tissues. Many xenobiotics inhibit steroid hormone production as a result of
interactions with cytochrome P450-containing hydroxylases in adrenal mitochondria or
microsomes. For example, metyrapone, a compound used clinically in the evaluation of
pituitary-adrenocortical function, binds to various cytochromes P450 in the adrenal, preventing
the interactions of steroid substrates with the enzymes and inhibiting steroidogenesis. The
mineralocorticoid antagonist, spironolactone, and its major circulating metabolite, canrenone,
also competitively interact with adrenal steroid hydroxylases. In addition, spironolactone is
converted by adrenal microsomes to an unknown metabolite which promotes the destruction of
cytochromes P-450, decreasing the activities of steroid hydroxylases. Carbon tetrachloride is
similarly "activated" by adrenal microsomal mixed function oxidases resulting in a decline in
steroidogenic enzyme activity. Carbon tetrachloride (in the presence of NADPH) initiates lipid
peroxidation in adrenal microsomes but its toxic effects on steroid hydroxylases are fully
demonstrable when lipid peroxidation is inhibited by EDTA. A number of heavy metals,
including cadmium, also inhibit adrenal steroid hydroxylases. When incubated with adrenal
microsomes, cadmium does not affect cytochrome P-450 levels but decreases basal and
substrate stimulated NADPH-cytochrome P-450 reductase activity. Although inhibitory effects
of many chemicals on steroidogenesis have been described, the toxicological significance as
well as definitive mechanisms of action have in most cases yet to be determined.

There are numerous substances which are known
to interfere with the production of steroid hormones. The types of compounds range from therapeutic and diagnostic agents to environmental toxins

and chemical carcinogens. In addressing the topic
of chemical suppression of steroidogenesis I shall
not attempt to catalog all of those compounds.
Instead, this presentation will concentrate on a few
different classes of chemical agents with the objective of illustrating several mechanisms through
which chemicals can affect steroid hormone production. For the sake of simplicity and uniformity, only
the effects of chemicals on steroidogenesis in the
adrenal cortex will be discussed although in many
cases similar effects are also manifested in other
steroid-producing tissues. Furthermore, in keeping
with the theme of this conference, greater emphasis will be placed on those compounds whose effects
on steroidogenesis are more in the realm of toxicology than on those drugs which have been developed
specifically to inhibit steroidogenesis.
*Department of Physiology, West Virginia University, School
of Medicine, Morgantown, West Virginia 26506.
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Before discussing the actions of chemicals on
steroidogenesis, it is important to introduce some
background material on the types of enzymatic
reactions involved in the production of steroid
hormones so that the actions of chemicals on these
enzymes can be more fully appreciated. Figure 1
illustrates a portion of the steroidogenic pathway
which exists in the adrenal cortex. Some of the
pathway overlaps with that in other steroidogenic
tissues. However, production of glucocorticoids,
such as cortisol, and of mineralocorticoids, like
aldosterone, is specific for the adrenal. Of particular interest are the role of cholesterol as the
common precursor to all steroid hormones and the
number of hydroxylation reactions involved in the
steroidogenic pathway. For example, note the 111,
18, 17a, and 21-hydroxylases as well as the cholesterol sidechain cleavage reaction which includes 2
hydroxylation steps (1, 2). Thus, hydroxylases are
critically important in steroidogenesis and as will
be seen, represent the sites of action of many
chemicals which influence steroidogenesis.
The adrenal steroid hydroxylases are typical
mixed function oxidases which contain the heme119
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FIGURE 1. Pathways for the production of glucocorticoids and
mineralocorticoids in the adrenal cortex.

protein, cytochrome P-450. They are similar to
those hepatic enzymes involved in the oxidative
metabolism of drugs, carcinogens and other
xenobiotics (3, 4). All require NADPH and molecular 02 as cofactors and are membrane-bound enzymes. Some are located in mitochondria and others
in the endoplasmic reticulum of the cell (1-4). The
mitochondrial and microsomal enzymes differ
somewhat in their composition but for the purpose
of this discussion, all can be thought of as two
functional units, the cytochrome P-450 to which the
steroid substrate binds, and a reductase component
which provides electrons derived from NADPH to
the cytochrome P-450. Once the substrate binds to
the cytochrome P-450, the reductase provides electrons to reduce the substrate-cytochrome complex
and also to promote activation of oxygen for incorporation into the steroid nucleus. The specific site
of hydroxylation of the steroid as well as the
substrate specificity of the enzyme is governed by
the cytochrome P-450 component. The number of
different cytochromes P-450 involved in steroidogenesis has yet to be determined, but it is possible,
perhaps even likely, that each hydroxylase contains
its own distinct cytochrome P-450 moiety. Both the
reductase and cytochrome P-450 components of the
enzyme are essential for hydroxylase activity.
A large number of the chemicals which have been
employed clinically as inhibitors of steroidogenesis
interact with various cytochromes P450 in steroidproducing tissues and inhibit the binding of normal
steroid substrates, thereby decreasing hydroxylase
activities (5). One of the best known and most
thoroughly studied of this group of compounds is
the pyridine derivative, metyrapone (SU-4885),
which is widely used in the evaluation of pituitaryadrenocortical function. By inhibiting cortisol pro120

duction, metyrapone should elicit an increase in
pituitary ACTH secretion and thereby serves as a
test of pituitary secretory reserve (5).
When metyrapone is added to adrenal mitochondrial preparations, it produces a characteristic
difference spectrum, indicative of its binding to
cytochromes P-450 (6). The spectrum is characterized by an increase in absorbance at about 425 nm
and a decrease at about 400 nm and is known as a
type II spectral change. The size of the spectrum
increases with increasing concentrations of metyrapone until its binding sites on the enzyme are
saturated. In the presence of metyrapone the size
of the spectral change resulting from substrate
interactions with adrenal mitochondrial cytochromes
P-450 is diminished (5, 6), illustrating the mechanism of action of the drug on steroid hydroxylation
reactions.
Although originally proposed to be a relatively
specific ll,B-hydroxylase antagonist, metyrapone
has been found to inhibit various other steroid
hydroxylation reactions, including 18- and 19-hydroxylation and cholesterol sidechain cleavage (5,
7). Each of these enzymes is located in mitochondria
and the results of several early studies suggested
that adrenal microsomal hydroxylases were not
affected by metyrapone. Neither 21-hydroxylase
nor 17a-hydroxylase activity was inhibited by
metyrapone in rat or bovine adrenals (8, 9). However, the specificity of the actions of metyrapone
appears to be species-dependent (10). In the rat
adrenal (Fig. 2), for example, concentrations of
metyrapone which produced inhibition of mitochondrial 11,-hydroxylation 1Wad no effects on microsomal
21-hydroxylase activity. In the guinea pig (Fig. 3),
by contrast, metyrapone had similar effects on
ll3-and 21-hydroxylation. Observations such as
these indicate that care must be taken when using
compounds like metryapone for experimental purposes since the specificity of their actions is not as
great as some earlier studies suggested and is
influenced by a number of variables.
0
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Another compound which is used clinically and
which has been shown to affect steroidogenesis is
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Table 1. Effects of spironolactone administration to guinea
pigs on cortisol production by adrenal slices.a

-j

Body weight, g
Adrenal weight, mg/pair
Cortisol production by adrenal
slices, nmoles/lOOmg/hr
-ACTH
+ACTH

0 50

z
0
IL

0

to0
H

a

21-HYDROXYLAE

b

00

Control

Spironolactone

657 + 12
340 ± 17

635 + 10
358 ± 10

31.2 ± 3.9
64.7 ± 7.2

13.2 2.2b
29.5 ±4.lb

For experimental details, see Greiner et al. (15).
p < 0.05 (vs. controls).
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FIGURE 2. Effects of metyrapone on 1113- and 21-hydroxylase
activities in rat adrenal mitochondria and microsomes, respectively. See Greiner et al. (10) for experimental details.
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FIGURE 3. Effects of metyrapone on 11,- and 21-hydroxylase
activities in guinea pig adrenal mitochondria and microsomes, respectively. See Greiner et al. (10) for experimental
details.
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the mineralocorticoid antagonist, spironolactone (SL).
SL is used as a diuretic and in the treatment of
some types of hypertension. Several clinical observations indicated that SL might interfere with
adrenal steroidogenesis in man (11, 12) and prompted
a number of studies on its effects in experimental
animals (13-1 7).
Following the administration of SL (25 mg/kg/day
for 3 days) to guinea pigs there was a decline in
cortisol production by adrenal sections in vitro
(Table 1) (15). The deficit was apparent whether or
not the adrenals were incubated with ACTH to
stimulate steroidogenesis. Indirect effects of SL on
the adrenal cortex resulting from inhibition of
ACTH secretion were excluded by comparing the
actions of SL with those of cortisone, a potent
inhibitor of pituitary ACTH secretion (15). Once
the inhibitory effect of SL on adrenocortical function was established, further studies were carried
out to determine its mechanism of action as well as
the role of canrenone, the major circulating metabolite of SL, in the actions of SL on the adrenal.
Either SL or conrenone administration to guinea
pigs decreased the activities of several steroid
hydroxylases in both adrenal mitochondria and
microsomes (Table 2) (16). The effects of SL on the
microsomal enzymes were greater than those of
canrenone. The decline in steroidogenic activity
could be attributed in part to the direct interactions
of SL and canrenone with steroid hydroxylases.
Both compounds produced type I difference spectra
in adrenal mitochondria and microsomes, indicative
of binding to cytochrome(s) P-450, and interfered
with the binding of steroid substrates to cytochromes P-450 (16). As a result, SL and canrenone
were direct inhibitors ofmitochondrial and microsomal
steroid hydroxylation in vitro (Figs. 4 and 5). Each
compound produced a concentration-dependent inhibition of mitochondrial 11-hydroxylation and
microsomal 21-hydroxylation. The effects of canrenone
on both enzymes were greater than those of SL.
Thus, the relative potencies in vitro were opposite
those obtained after in vivo administration of SL
121

Table 2. Effects of spironolactone or canrenone administration to guinea pigs on adrenal steroid hydroxylases.a
Enzyme activities, nmole/min/mg protein
Canrenone
Spironolactone
Control

Mitochondrial
ll-Hydroxylase
Cholesterol SCC
Microsomal
17a-Hydroxylase
21-Hydroxylase
a

2.4 ± 0.1
0.28 ± 0.03

1.5 ± 0.1b
0.15 ±

1.7 + 0.1b
0.17 ± 0.02b

6.9 ± 0.7
4.4 ± 0.3

2.3 ± 0.3b
1.6 ± 0.2b

4.5 ± 0.5bc
2.9 ± 0.lbC

For experimental details, see Greiner et al. (16).
0.05 (vs. controls)
0.05 (vs. spironolactone-treated)

bp <
cp <

and canrenone (Table 2). However, direct competition for binding to cytochromes P-450 provided only
part of the explanation for the actions of SL on
steroidogenesis. SL treatment also resulted in a
decline in the amount of cytochromes P-450 in
adrenal mitochondria and microsomes (Table 3).
Canrenone, in contrast, had no effect on cytochrome P-450 concentrations, which may account
for the greater potency of SL in vivo on steroidogenic
enzymes.
The effect of SL on adrenal cytochrome P-450
levels could also be demonstrated in vitro under the
appropriate experimental conditions (14, 16). When

adrenal microsomes were incubated with SL plus
NADPH, a decline in cytochrome P-450 levels
resulted (Fig. 6). Omission of either SL or NADPH
from the incubation medium eliminated the effect.
In contrast, incubation with canrenone, with or
without NADPH, did not affect cytochrome P-450
content. The decline in cytochrome P-450 levels
caused by SL plus NADPH was accompanied by a
fall in microsomal heme content. The specificity of
action of SL on cytochrome P-450 is indicated by
the absence of effects on the other major adrenal
microsomal hemeprotein, cytochrome b5 (Fig. 6).
These and other observations indicate that SL is
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FIGURE 4. Effects of spironolactone and canrenone in vitro on
11,-hydroxylase activity in guinea pig adrenal mitochondria.
See Greiner et al. (16) for experimental details.
122

0

5x10-6

10-5

2x 10-5

5x

10-5

10-4

CONCENTRATION OF DRUG (M)

FIGURE 5. Effects of spironolactone and canrenone in vitro on
21-hydroxylase activity in guinea pig adrenal microsomes.
See Greiner et al. (16) for experimental details.
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Table 3. Effects of spironolactone or canrenone administration to guinea pigs on adrenal mitochondrial and microsomal
cytochrome P-450 content.a

Adrenal weight, mg/pair
Protein, mg/g
Mitochondrial
Microsomal
Cytochrome P-450, nmole/mg protein
Mitochondrial
Microsomal
a

Control

Spironolactone

Canrenone

446 ± 31

502 ± 33

472 ± 15

37.6 ± 1.2
48.6 ± 1.6

36.3 ± 0.8
43.4 ± 1.2

36.1 ± 0.8
43.0 ± 1.9

0.46 ± 0.03
1.99 ± 0.11

0.38 ±
1.32 ± 0.12b

0.45 ± 0.02c
1.82 ± 0.10c

For experimental details, see Greiner et al. (16).
0.05 (vs. controls)
0.05 (vs. spironolactone-treated)

bp <
cp <

converted by the adrenal cortex to a metabolite
which promotes the destruction of adrenal cytochrome(s) P-450. In subsequent studies (17) it was
found that only analogs of SL with the sulfur group
at the C-7 position decrease cytochrome P-450
levels. Thus, SL appears to interfere with
steroidogenesis through two related but distinct
mechanisms: (1) SL and/or one or more of its
metabolites compete(s) with normal steroid substrates for binding sites on cytochrome P-450, and
(2) SL is converted to a toxic metabolite by adrenal
enzymes, resulting in the destruction of cytochromes
P-450 and loss of hydroxylase activity. The identity
of the active metabolite is presently unknown and is
now being pursued in several laboratories.
Another compound which requires conversion to
Spironoloctone
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Cytoc hrome
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FIGURE 6. Effects of preincubation of guinea pig adrenal microsomes with spironolactone or canrenone on cytochrome
P-450, heme, and cytochrome b5 levels. See Greiner et al.
(16) for experimental details.
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an active metabolite before its toxic effects are
manifested is carbon tetrachloride (CC14) (18). The
hepatotoxic effects of CC14 are well known and have
been extensively studied for many years. Less well
known is that CC14 poisoning also produces adrenal
necrosis in man as well as in some experimental
animals (19). Until recently, little was known about
the specific actions of CC14 on the adrenal cortex.
When CC14 was given to guinea pigs and the
animals killed 48 hr later, changes in adrenal
microsomal steroid hydroxylases were found (Table
4). Both 17a- and 21-hydroxylase activities in ad
enal microsomes were decreased by CC14 treatment
but the mitochondrial ll,-hydroxylase was unaffected. Similarly, microsomal but not mitochondrial
cytochrome P-450 levels were decreased by CC14.
It is reasonably well established that in the liver,
the toxic effects of CC14 depend upon its conversion
by cytochrome P-450-containing enzymes to the
highly reactive trichloromethyl radical (18). However, the nature of the subsequent events in CC14
toxicity is somewhat controversial; the controversy
is centered about the involvement of lipid peroxidation. The two prevalent hypotheses for the
mechanism of action of CC14 include the conversion
of CC14 to the trichloromethyl radical. However,
one hypothesis advocates a direct attack of the
radical on cellular macromolecules, including cytochromes P-450, resulting in the destruction of
enzymes. The other hypothesis proposes an obligatory role for lipid peroxidation in the actions of
CCl4; that is, an attack on the unsaturated fatty
acids of membrane phospholipids by the trichloromethyl radical, resulting in hydroperoxide fonnation and membrane disruption and secondarily
causing a loss of cytochrome P-450 and associated
enzyme activities.
In examining the effects of CC14 on adrenal
steroidogenic enzymes, we attempted to determine
if lipid peroxidation was involved. Lipid peroxidation
activity was assayed as the formation of malon123

Table 4. Effects of carbon tetrachloride (CC14) administration to guinea pigs on adrenal microsomal and mitochondrial steroid
hydroxylases.a

Mitochondria

Microsomes

CC14

Control
Protein, mg/g adrenal
Cytochrome P-450, nmole/mg protein
17oa-Hydroxylation, nmole/min/mg protein
21-Hydroxylation, nmole/min/mg protein
111-Hydroxylation, nmole/min/mg protein

41.7
1.8
7.6
2.9

3.1
0.2
0.6
0.2

±
±
±
±

-

39.8
0.8
4.1
1.7

± 4.1
+ 0.2*
± 0.5*
± 0.2*
-

Control

CCl4

34.2 ± 2.9
0.5 ± 0.1
-

33.8 ± 2.8
0.5 ± 0.1

2.4 ± 0.2

2.5 ± 0.2

a
CC14 was given to adult male guinea pigs as a single intraperitoneal injection 48 hr prior to sacrifice at a dose of 0.4 ml/kg body
weight.
* p < 0.05 (vs. controls)

aldehyde, one of the breakdown products of
hydroperoxides. In several preliminary experiments
we found that the effects of CC14 on adrenal
microsomal enzymes were readily demonstrable in
vitro (Fig. 7). When CC14 was incubated with
adrenal microsomes plus NADPH, a decline in the
rates of steroid 17a- and 21-hydroxylation resulted.
The decline in enzyme activity was dependent upon
the duration of incubation and required the presence of NADPH, suggesting that CC14 was converted to an active metabolite by adrenal microsomes.
Incubation with CC14 plus NADPH also produced a
decrease in adrenal microsomal cytochrome P-450
content and, as previously found in the liver, CC14
7a - Hydroxylase

21- Hydroxylose

FIGURE 7. Effects of preincubation of guinea pig adrenalmi-E
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FIGURE 7. Effects of preincubation of guinea pig adrenal microsomes with carbon tetrachloride (CC14) on steroid
hydroxylation and lipid peroxidation. Microsomes (2.0 mg
protein/ml) were incubated in 1.15% KCI-0.05M Tris-HCI
(pH 7.4) for 60 min at 3700 under air. NADPH (0.4mM)
and/or CC14 (5 pl/ml) were added prior to the start of
incubation. Lipid peroxidation was measured as the rate of
production of malonaldehyde (MDA).
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plus NADPH stimulated lipid peroxidation in adrenal microsomes.
To determine if lipid peroxidation was essential
for the toxic effects of CC14 on adrenal steroidogenic
enzymes, similar incubations were carried out in
the presence and absence of EDTA, a well known
inhibitor of lipid peroxidation (Fig. 8). The lipid
peroxidation initiated by CC14 plus NADPH was
almost completely inhibited when 1.0 mM EDTA
was also present in the incubation medium.
Nonetheless the decreased in 17a- and 21-hydroxylase
activities produced by NADPH plus CC14, as well
as the decline in cytochrome P-450 levels, were
unaffected by the EDTA. The time course for the
decreases in 17a- and 21-hydroxylase activities
during incubation of adrenal microsomes with CC14
plus NADPH was also unaffected by EDTA (Fig.
9). These observations indicate that CC14 can indeed stimulate lipid peroxidation in adrenal microsomes but that the lipid peroxidation is not obligatory
for the toxic effects of CC14 on adrenal microsomal
enzymes.
Although we have not been able to demonstrate
any cause and effect relationship between lipid
peroxidation and CC14 toxicity, the significance of
lipid peroxidation in relation to steroidogenic enzyme activity remains an interesting question. It is
known that lipid peroxication has deleterious effects on the membranous components of cells (18)
and steroid hydroxylases are membrane-bound enzymes. However, relatively little is known about
lipid peroxidation in steroid-producing tissues. The
relationship between lipid peroxidation and steroidogenesis may provide fertile ground for future
research since some of the factors known to promote lipid peroxidation, such as ascorbate, iron,
and NADPH, are found in relatively high concentrations in steroidogenic tissues like the adrenal
cortex.
The compounds discussed thus far all exert
effects on steroidogenesis as a result of actions on
the cytochrome P450 portion of steroid hydroxylases.
Environmental Health Perspectives
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A number of heavy metals also inhibit steroid
hydroxylation reactions but apparently via a different mechanism. Many metals including cadmium
have been shown to exert inhibitory effects on
hepatic cytochrome P-450-containing enzymes (20,
I 7a

-

21), and recently we found that cadmium administration to guinea pigs produced substantial decreases in adrenal steroid hydroxylases as well.
The actions of cadmium on adrenal microsomal
steroid metabolism are also demonstrable in vitro.
Incubation of adrenal microsomes with Cd at 37°C
produced concentration-dependent decreases in steroid 21-hydroxylase activity (Fig. 10). Similar changes
in microsomal 17a-hydroxylase and mitochondrial
11-hydroxylase activities were also observed. The
decreases in 21-hydroxylase activity were proportional to the length of incubation and were
temperature-dependent. Incubations at 0°C had no
effects on enzyme activity.
The time-course for the changes in 21-hydroxylase
activity in the presence of 50,uM cadmium is shown
in Figure 11. Incubation for 60 min produced almost
complete loss of enzyme activity. Despite the large
decrease in the rate of steroid metabolism, there
was no change in cytochrome P-450 content in the
microsomes. In addition, cadmium did not affect
the interaction of steroid substrates with cytochromes P-450, as indicated by the absence of
change in the size of the type I spectral change
produced by 17a-hydroxyprogesterone, a substrate
for 21-hydroxylation. However, cadmium produced
decreases in NADPH-cytochrome P-450 reductase
activity which were proportionately similar to the
decreases in 21-hydroxylase activity. Thus, cadmium appears to exert its inhibitory effects on
steroidogenesis via selective actions on the reduc-
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FIGURE 10. Effects of preincubation of guinea pig adrenal
microsomes with cadmium on 21-hydroxylase activity. Microsomes (2.0 mg protein/ml) were incubated in 1.15%
KCl-0.05M Tris-HCl (pH 7.4) for 30 min at 37°C under air in
the presence of varying concentrations of cadmium chloride.
After incubation, 21-hydroxylase activity was assayed as the
rate of conversion of 17-hydroxyprogesterone to 11-deoxycortisol.
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metabolism resulting from the incubation of microsomes with
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reductase activity was determined in the presence of
17-hydroxyprogesterone (5 x 10-5M), a substrate for
21-hydroxylation. The type I spectral change was obtained
by addition of 5 x 10M 17-hydroxyprogesterone to adrenal
microsomal suspensions.

tase portion of the steroid hydroxylase and not on
the cytochrome P-450. Preliminary studies indicate
that other metals such as zinc and lead act in a
similar manner.
The compounds which have been discussed in this
presentation are but a few of the many chemicals
that can affect steroidogenesis. The toxicological
significance of these agents as well as definitive
mechanisms of action have in most cases yet to be
established but represent areas of ongoing investigation in a number of laboratories. However, it
126

should be borne in mind that there also remain
many gaps in our knowledge of the fundamental
mechanisms in the regulation of steroid hormone
production. Only with a more complete understanding of the processes involved in steroidogenesis are
we likely to be able to fully comprehend the actions
of chemicals on this important metabolic pathway.
The technical assistance of Marlene Pope, Peggy Johnson, and
Jo Zulkoski is gratefully acknowledged. These investigations
were supported by grants from the USPHS (CA 22152) and the
Department of Energy (DE-AT-21-79-MC-11284).
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